Cash from Investing (Quarterly) Chart

View Cash from Investing (Quarterly) for VTIAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Investing (Quarterly) Chart
Start Trial

Historical Cash from Investing (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
June 30, 2026 -0.774M
March 31, 2026 -0.9933M
December 31, 2025 -5.495M
September 30, 2025 -2.053M
June 30, 2025 -6.600M
March 31, 2025 -0.5925M
December 31, 2024 -0.8393M
September 30, 2024 -0.8842M
June 30, 2024 -0.51M
March 31, 2024 -1.371M
December 31, 2023 -0.4728M
September 30, 2023 -2.532M
June 30, 2023 -0.825M
March 31, 2023 -1.420M
December 31, 2022 -0.0235M
September 30, 2022 -2.128M
June 30, 2022 -2.140M
March 31, 2022 0.1772M
December 31, 2021 24.34M
September 30, 2021 -0.243M
June 30, 2021 -0.4156M
March 31, 2021 -0.1253M
December 31, 2020 -0.1993M
September 30, 2020 -0.2231M
June 30, 2020 0.2181M
Date Value
March 31, 2020 -0.1223M
December 31, 2019 -0.7784M
September 30, 2019 -0.3124M
June 30, 2019 -0.1708M
March 31, 2019 -0.2941M
December 31, 2018 -0.9083M
September 30, 2018 1.966M
June 30, 2018 0.3311M
March 31, 2018 -0.4621M
December 31, 2017 -7.620M
September 30, 2017 -0.6445M
June 30, 2017 -6.995M
March 31, 2017 -0.2377M
December 31, 2016 -0.6962M
September 30, 2016 0.5078M
June 30, 2016 -0.1897M
March 31, 2016 -0.2933M
December 31, 2015 -0.2222M
September 30, 2015 -0.7047M
June 30, 2015 -3.726M
March 31, 2015 -0.6116M
December 31, 2014 -0.1224M
September 30, 2014 -0.1365M
June 30, 2014 -0.1604M
March 31, 2014 -0.1672M

Cash From Investing Definition

Represents the net cash flow from the company's investing activities. Investing activities represent the movement in the company's long-term assets.

Read full definition.

Cash from Investing (Quarterly) Range, Past 5 Years

View Cash from Investing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Investing (Quarterly) Benchmarks

View Cash from Investing (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG -312.01M
Global Cord Blood Corp. --
Cryo-Cell International, Inc. 0.035M
Rhön-Klinikum AG --
Cordlife Group Ltd. -1.838M